CEB-01 in Locally Resectable Pancreatic Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

Spain

Hospital Clínico y Provincial de Barcelona, Barcelona, Catalonia

H. Clínico San Carlos, Madrid, Madrid

H.U. Virgen del Rocío, Seville, Sevilla

H. Clínico Univ. de Valencia, Valencia, Valencia